Shikha Sharma - Dr Reddys Non-Executive Independent Director

RDY -- USA Stock  

USD 38.01  0.07  0.18%

  Director
Smt. Shikha Sharma is NonExecutive Independent Director of the Company. Ms. Shikha Sharma was the Managing Director CEO of Axis Bank, Indias third largest private sector bank from June 2009 upto December 2018. As a leader adept at managing change, she led the Bank on a transformation journey from being primarily a corporate lender to a bank with a strong retail deposit franchise and a balanced lending book. Ms. Sharma has more than three decades of experience in the fi nancial sector, having begun her career with ICICI Bank Limited in 1980. During her tenure with the ICICI Group, she was instrumental in setting up ICICI Securities. As Managing Director CEO of ICICI Prudential Life Insurance Company Limited, she led the company to become the No. 1 private sector life insurance company in India. Ms. Sharma holds directorships in Ambuja Cements Limited and Tata Global Beverages Limited
Age: 59  Director Since 2019  MBA    
91 40 4900 2900  http://www.drreddys.com
Sharma has an MBA from the Indian Institute of Management, Ahmedabad, India, B.A. in Economics and PGD in Software Technology from National Centre for Software Technology, Mumbai, India.

Management Efficiency

The company has Return on Asset of 5.42 % which means that on every $100 spent on asset it made $5.42 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 15.08 % implying that it generated $15.08 on every 100 dollars invested.
The company has 811.73M in debt with debt to equity (D/E) ratio of 23.5 . This implies that the company may be unable to create cash to meet all of its financial commitments. Dr Reddys Laboratories has Current Ratio of 1.85 which is typical for the industry and considered as normal.

Similar Executives

Showing few of many executives

DIRECTOR Since

Arthur RyanRegeneron Pharmaceuticals
2003
Sangeeta BhatiaVertex Pharmaceuticals Incorpor
2015
Gregory NordenZoetis
2013
Yuchun LeeVertex Pharmaceuticals Incorpor
2012
Margaret McGlynnVertex Pharmaceuticals Incorpor
2011
Bradley AlfordPerrigo Company plc
2017
Yingqi XiaOrigin Agritech Limited
2010
Herman MorrisPerrigo Company plc
1999
Theodore SamuelstoPerrigo Company plc
2017
David BullockOrigin Agritech Limited
2015
William YoungVertex Pharmaceuticals Incorpor
2014
Jeffrey KindlerPerrigo Company plc
2017
Laurie BrlasPerrigo Company plc
2016
Gary KunklePerrigo Company plc
2009
Paul BisaroZoetis
2015
Huda ZoghbiRegeneron Pharmaceuticals
2016
William SteereZoetis
2013
Linda RhodesZoetis
2017
Terrence KearneyVertex Pharmaceuticals Incorpor
2011
David GreenwayVertex Pharmaceuticals Incorpor
2017
Ellen HoffingPerrigo Company plc
2008

Entity Summary

Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India. Dr Reddys operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 21966 people.Dr Reddys Laboratories Ltd (RDY) is traded on BATS Exchange in USA and employs 21,966 people.

Dr Reddys Laboratories Leadership Team

G Prasad, Co-Chairman of the Board, Chief Executive Officer, Managing Director
MARC KIKUCHI, Chief Executive Officer, North America Generics
Hans Hasler, Additional Independent Director
Leo Puri, Non-Executive Independent Director
Sandeep Poddar, Compliance Officer, Company Secretary
Satish Reddy, Co-Chairman of the Board
Kedar Upadhye, IR Contact Officer
Samiran Das, Executive Vice President Head - FTO and GGPM
Sauri Gudlavalleti, Global Head of Integrated Product Development Organization
YUGANDHAR PUVVALA, Global Head of Supply Chain
Amit Biswas, Executive Vice President - Integrated Product Development
Ravi Bhoothalingam, Non-Executive Independent Director
Alok Sonig, Senior Vice President & India Business Head (Generics)
Allan Oberman, Non-Executive Independent Director
J Ramachandran, Executive Vice President-Management Systems and Corporate Initiatives
Prasad Menon, Lead Non-Executive Independent Director
K Rao, Sr. Vice President & Head ? Chemical Technical Operations (CTO)
Abhijit Mukherjee, COO
Anil Namboodiripad, Global Head of Proprietary Products
Saumen Chakraborty, President, Chief Financial Officer and Global Head of ITBPE, Legal & Compliance and FMCRE
SANJAY SHARMA, Global Head of Manufacturing
Shikha Sharma, Non-Executive Independent Director
Sridar Iyengar, Non-Executive Independent Director
Ganadhish Kamat, Executive Vice President and Global Head-Quality
Sripada Chandrasekhar, President, Global Head of HR and Member of Management Council
Omkar Goswami, Non-Executive Independent Director
Erez Israeli, Chief Operating Officer and Global Head of Generics & PSAI
Kalpana Morparia, Non-Executive Independent Director
Bharat Doshi, Non-Executive Independent Director
J Moreau, Non-Executive Independent Director
Raymond Vre, Global Head of Biologics
Raghav Chari, Senior Vice President - Proprietary Products
Bruce Carter, Non-Executive Independent Director
Saunak Savla, IR Contact Officer
Ashok Ganguly, Non-Executive Independent Director
Umang Vohra, Executive Vice President Head - North America Generics
M Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets)
Cartikeya Reddy, Senior Vice President Head - Biologics
Anupam Puri, Non-Executive Independent Director
Archana Bhaskar, Chief Human Resource Officer
Deepak Sapra, Global Head of PSAI

Stock Performance Indicators

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module

Currently Active Assets on Macroaxis

FB   
Purchased few shares of
few hours ago
Traded for 188.14
VMW   
Purchased a lot of shares of
few hours ago
Traded for 150.35
V   
Purchased few shares of
few hours ago
Traded for 175.29
CRM   
Purchased a lot of shares of
few hours ago
Traded for 152.77
F   
Purchased over 300 shares of
few hours ago
Traded for 9.25
Additionally take a look at Your Equity Center. Please also try Commodity Channel Index module to use commodity channel index to analyze current equity momentum.
Search macroaxis.com